Calmangafodipir

Star0

DB18398InvestigationalSmall molecule

Calmangafodipir: Overview.

Formula / weight: C₁₁₀H₁₅₀Ca₄MnN₂₀O₇₀P₁₀ · 3397.468 g/mol (avg)
Also known as: Calcium,n,n'-1,2-ethanediylbis(n-((3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)glycine) manganese complexes trisodium trihydrogen manganate · Calmangafodipir (ca4mn(dpdp)5) · Pledox · Tetracalcium monomanganese penta(dipyridoxyl diphosphate)
Code names: PP100-01

Resolves to

Compound

UNIIN0JZU0WGU5CAS1401243-67-1

Structure

InChIKeyQAOJLUYEMFXJGX-UHFFFAOYSA-DSMILES

[Ca++].[Ca++].[Ca++].[Ca++].[Mn++].CC1=NC=C(COP(O)([O-])=O)C(CN(CCN(CC(O)=O)CC2=C(COP(O)([O-])=O)C=NC(C)=C2O)CC(O)=O)=C1O.CC1=NC=C(COP(O)([O-])=O)C(CN(CCN(CC(O)=O)CC2=C(COP(O)([O-])=O)C=NC(C)=C2O)CC(O)=O)=C1O.CC1=NC=C(COP(O)([O-])=O)C(CN(CCN(CC(O)=O)CC2=C(COP(O)([O-])=O)C=NC(C)=C2O)CC(O)=O)=C1O.CC1=NC=C(COP(O)([O-])=O)C(CN(CCN(CC(O)=O)CC2=C(COP(O)([O-])=O)C=NC(C)=C2O)CC(O)=O)=C1O.CC1=NC=C(COP(O)([O-])=O)C(CN(CCN(CC(O)=O)CC2=C(COP(O)([O-])=O)C=NC(C)=C2O)CC(O)=O)=C1O

What you can answer from here — as of April 23, 2025

4Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Calmangafodipir, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account